Dysplastic nevus screening

Dysplastic nevus Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Dysplastic nevus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dysplastic nevus screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dysplastic nevus screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dysplastic nevus screening
CDC on Dysplastic nevus screening
Dysplastic nevus screening in the news
Blogs on Dysplastic nevus screening
Directions to Hospitals Treating Dysplastic nevus
Risk calculators and risk factors for Dysplastic nevus screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients with dysplastic nevus should undergo regular screening to prevent progression to melanoma.

Screening

According to the National Cancer Institute, physicians believe that dysplastic nevi are more likely than ordinary moles to develop into a type of skin cancer called melanoma. Because of this, moles should be checked regularly by a physician or nurse specialist, especially if they look unusual; grow larger; or change in color, or outline; or if any changes occur.